Navigation Links
Study reveals rise in prostate biopsy complications and high post-procedure hospitalization rate
Date:9/21/2011

imple outpatient procedures," adds Schaeffer, an associate professor at the Johns Hopkins University School of Medicine and its Brady Urological Institute.

In their study, the researchers examined the frequency of biopsy related complications that required hospitalization in more than 17,400 men age 65 and older from 1991 to 2007. They compared these rates to a cohort of 134,977 men during the same time period with similar characteristics who did not undergo a prostate biopsy. The researchers only looked at hospital admissions, not men whose complications were treated in an emergency department or outpatient setting.

While the rate of hospitalization following prostate biopsy has declined steadily since 1991, the researchers found that the rate of hospitalization during the time period was still two-fold higher among the men who had a biopsy (6.9 percent compared to 2.9 percent).

There was also a steady rise in the rate of serious infection-related complications. At the onset of the study in 1991, fewer than 0.5 percent of men were admitted to the hospital because of an infection diagnosed following a prostate biopsy. This rate remained stable until 2000, when rates of infection-related complications began to increase to more than 1.2 percent in 2007.

"Antibiotics are routinely given to men at the time of biopsy, and the fact that infections serious enough to cause hospital admissions have been on the rise makes us think that these types of complications are occurring because of a steady increase in antimicrobial resistance rates in America," says Schaeffer.

Co-author H. Ballentine Carter, M.D., professor of urology and oncology at the Johns Hopkins University School of Medicine, says, "Based on these findings, we believe that more needs to be done to reduce potential complications. It is important for urologists to determine if a biopsy is appropriate for an individual patient and also if the patient is at increased risk
'/>"/>

Contact: Ellen Beth Levitt
eblevitt@jhmi.edu
410-955-5307
Johns Hopkins Medical Institutions
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Japan Reactor Fallout Reached San Francisco Bay Area: Study
2. Alzheimers disease: The first prevention study of its kind
3. Large study finds genetic overlap between schizophrenia, bipolar disorder
4. UT awarded NIH grants to study prevention and treatment of neurodegenerative and vascular diseases
5. Infant mortality linked to subsequent risk of stillbirth finds new US study
6. Cash, Luxury Goods Really Do Get People Salivating: Study
7. John Theurer Cancer Center among first clinical trial sites to join landmark MMRF study
8. MRI Can Spot Breast Cancer in High-Risk Women: Study
9. Long-term effectiveness of new family planning method shown in study
10. UCSF study identifies weakness in heart attack therapy
11. Diverticulitis Surgery More Dangerous for Older Black Patients: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... Sharenote, a leading web-base electronic healthcare software (EHR) is ... in Louisiana. The entrepreneurial trio behind Sharenote, will travel ... providers with the tools and resources to monitor key ... network. , Find out why Sharenote is the ... than 250 practices. , Four Day Schedule ...
(Date:6/1/2015)... There’s never a good time to be sick and need ... , As of June 1, OSF HealthCare is offering ... the Internet. Patients throughout Illinois can access care whenever they ... busy. We know that getting in to see a provider ... it easier,” said Jeffry Tillery, MD, Chief Transformation Officer for ...
(Date:6/1/2015)... Hexagon Geospatial is pleased to announce the launch ... service that provides on-demand access to the company’s world-class ... IMAGINE and GeoMedia are now available ... subscription model for delivering software products as an online ... quickly and easily access the right tools that help ...
(Date:6/1/2015)... June 01, 2015 Good360 announced ... the Irene W. and C.B. Pennington Foundation, Louisiana’s ... board of directors. Bertman joins Good360 just before ... this summer. , "Bringing with her many years ... am thrilled that Lori is joining the Good360 ...
(Date:6/1/2015)... Triple C announced today that they will be ... this year on RFD-TV. , From the humble, farm shop ... the today’s full line of rugged products, Triple C, Inc. ... , In this segment, American Farmer will explore how ... thrive in the tough conditions on North American ranches. Viewers ...
Breaking Medicine News(10 mins):Health News:OSF HealthCare Now Offering OSF OnCall 2Health News:OSF HealthCare Now Offering OSF OnCall 3Health News:Hexagon Geospatial Launches Cloud-Based Producer Online Suite 2Health News:Hexagon Geospatial Launches Cloud-Based Producer Online Suite 3Health News:Lori Bertman Joins Good360 Board of Directors 2Health News:Triple C to Be Featured in Upcoming Episode of American Farmer 2
... non-serious side effects , , FRIDAY June 27 (HealthDay News) ... marijuana plant don,t increase the risk of serious side ... non-serious side effects, Canadian scientists report. , The researchers ... British Columbia (UBC) examined adverse events reported in 31 ...
... (PTCB), the leading national program that has ... and congratulates the Florida House of Representatives ... requiring new standards for pharmacy technicians. The ... toward increasing patient safety for consumers. The ...
... /PRNewswire-FirstCall/,-- Schering-Plough Corp. (NYSE: SGP ) and ... the withdrawal of the New Drug Application (NDA) ... terminated the Schering-Plough/Merck Pharmaceuticals,respiratory joint venture, which was ... fixed-combination product that would combine loratadine and,montelukast. This ...
... 27 Health care facilities,in the U.S. are ... infections (HAI). Could there be hidden areas of,infection ... education program,from the production company Mission Critical attempts ... Areas of Infection,",( http://www.missioncriticaltv.com/index-8-1.html ) documents how an ...
... to the latest,report by the American Lung Association, Lung ... increasing while death rates due to other,leading causes of ... Chronic obstructive pulmonary disease (COPD) is expected to,become the ... American Lung Association publishes Lung Disease Data to serve ...
... a World Health Organization expert on E. coli ... Bioniche Life Sciences,Inc. (TSX: BNC), a research-based, technology-driven ... this week,entitled, "E. coli O157 Vaccine: Added Value ... from the food industry: Beef,dairy, and other agricultural ...
Cached Medicine News:Health News:Drugs With Marijuana Compounds Don't Boost Adverse Events 2Health News:Pharmacy Technician Certification Board (PTCB) Supports Florida's New Patient Safety Solution 2Health News:Pharmacy Technician Certification Board (PTCB) Supports Florida's New Patient Safety Solution 3Health News:Hidden Areas of Infection in U.S. Hospitals 2Health News:Hidden Areas of Infection in U.S. Hospitals 3Health News:American Lung Association Report Finds Lung Disease Death Rates Increasing While Cancer, Heart Disease and Stroke Death Rates Are Decreasing 2Health News:American Lung Association Report Finds Lung Disease Death Rates Increasing While Cancer, Heart Disease and Stroke Death Rates Are Decreasing 3Health News:Bioniche Hosts Veterinarians and Food Industry Reps at Two-Day E. coli O157:H7 Vaccine Conference 2Health News:Bioniche Hosts Veterinarians and Food Industry Reps at Two-Day E. coli O157:H7 Vaccine Conference 3Health News:Bioniche Hosts Veterinarians and Food Industry Reps at Two-Day E. coli O157:H7 Vaccine Conference 4Health News:Bioniche Hosts Veterinarians and Food Industry Reps at Two-Day E. coli O157:H7 Vaccine Conference 5
(Date:6/1/2015)... May 29, 2015 Research and Markets ... the "Global A Dialyzer Reprocessing Machine (A ... to their offering. The Global A ... Report 2014 is a professional and in-depth study ... reprocessing machine industry. The report provides a ...
(Date:6/1/2015)...  Boston Biomedical, an industry leader in the development ... (CSC) pathways, will present clinical data today on the ... at the 2015 American Society of Clinical Oncology (ASCO) ... Data presented at ASCO highlight the potential of ... leading to inhibition of the critical genes for maintaining ...
(Date:6/1/2015)... , June 1, 2015   OTC ... Open, Transparent and Connected financial marketplaces for 10,000 ... a San Diego -based biopharmaceutical ... on OTCQB®, America,s only public venture market for ... - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO "We,re ...
Breaking Medicine Technology:Global A Dialyzer Reprocessing Machine (A Dialyzer Reprocessor) Industry Report 2014 - Development Trends Forecasts to 2020 2Global A Dialyzer Reprocessing Machine (A Dialyzer Reprocessor) Industry Report 2014 - Development Trends Forecasts to 2020 3Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 2Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 3Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 4Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 5Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 6Boston Biomedical Data at ASCO 2015 Highlights Potential of Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 and BBI503 in Multiple Cancer Types 7OTC Markets Group Congratulates OncoSec Medical on NASDAQ Listing 2
... DIEGO, Dec. 20, 2010 Optimer Pharmaceuticals, Inc. ... Gregory Papaz has joined Optimer as Senior Vice ... the preparations for the planned commercialization of fidaxomicin. ... of experience in the healthcare and pharmaceutical industry ...
... XI,AN, China, Dec. 20, 2010 /PRNewswire-Asia-FirstCall/ -- DK Sinopharma, Inc. (OTC ... was honored at a grand awards ceremony on December 8, 2010 ... Paying Credit Rating on September 30, 2010. "We ... third time in a row that the Company has been rated ...
Cached Medicine Technology:Optimer Pharmaceuticals Appoints Gregory Papaz to New Position of Senior Vice President of Commercial Operations 2Optimer Pharmaceuticals Appoints Gregory Papaz to New Position of Senior Vice President of Commercial Operations 3DK Sinopharma, Inc. is Honored as 'A-class Taxpayer' for the Third Time 2DK Sinopharma, Inc. is Honored as 'A-class Taxpayer' for the Third Time 3
... Accurate Quantitation of DNA, RNA, Or Fluorescent ... and RNA is critical to life science research. ... way to measure quantities as small as 1ng/ml ... another set of excitation and emission filters, the ...
The Fluoroskan Ascent FL is equipped with both fluorometric and luminometric measurement technologies, providing a full coverage for fluorometric, glow and flash luminometric applications even in the...
... DyNA Quant™ 200 is a ... excitation and 460 nm emission. The ... the detection of double-stranded DNA using ... assay, which minimizes interference from the ...
... is a multifunctional single ... give you utmost flexibility ... and absorbance. Modulus operates ... dedicated luminometer, or a ...
Medicine Products: